Neurologiske bivirkninger af cancerimmunterapi med checkpointinhibitorer
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Forlagets udgivne version, 1,13 MB, PDF-dokument
Treatment with checkpoint inhibitors has revolutionised the treatment of many different cancers with a significant improvement in cancer survival. However, a different type of adverse effects is seen compared to standard chemotherapy called immune-related adverse effects (irAE). In this review, we give recommendations on how to diagnose and treat the most common and severe neurologic irAE. We advise clinicians to be cautious to classify neurologic irAE as well-known nosologic entities, since their presentation, cause and treatment often is different.
Bidragets oversatte titel | Neurological adverse effects of cancer therapy with checkpoint inhibitors |
---|---|
Originalsprog | Dansk |
Artikelnummer | V05200406 |
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 183 |
Udgave nummer | 2 |
Antal sider | 9 |
ISSN | 0041-5782 |
Status | Udgivet - 11 jan. 2021 |
- Drug-Related Side Effects and Adverse Reactions, Humans, Immunotherapy/adverse effects, Neoplasms/drug therapy
Forskningsområder
Links
- https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2021-01/v05200406_web.pdf
Forlagets udgivne version
ID: 288283903